+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Adult Hemoglobinopathy Testing: Global Strategic Business Report

  • PDF Icon

    Report

  • 174 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140730

Global Adult Hemoglobinopathy Testing Market to Reach $513.7 Million by 2030

The global market for Adult Hemoglobinopathy Testing estimated at US$368.6 Million in the year 2022, is projected to reach a revised size of US$513.7 Million by 2030, growing at a CAGR of 4.2% over the analysis period 2022-2030. HPLC Test, one of the segments analyzed in the report, is projected to record 3.9% CAGR and reach US$314.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mass Spectrometry segment is readjusted to a revised 4.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $98.2 Million, While China is Forecast to Grow at 6.6% CAGR

The Adult Hemoglobinopathy Testing market in the U.S. is estimated at US$98.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$110.4 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 3.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Select Competitors (Total 44 Featured) -

  • BioMedomics Inc.
  • Bio-Rad Laboratories, Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • PerkinElmer, Inc.
  • Streck, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Adult Hemoglobinopathy Testing - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for HPLC Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for HPLC Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for HPLC Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Hb Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Hb Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Hb Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Academic & Medical Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Academic & Medical Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Academic & Medical Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 22: World Adult Hemoglobinopathy Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: USA Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: USA 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: USA Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: USA 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: Canada 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: Canada 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
JAPAN
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: Japan 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: Japan 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
CHINA
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: China Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: China 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: China Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: China 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
EUROPE
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 52: Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 55: Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
FRANCE
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 57: France Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 58: France 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 60: France Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 61: France 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
GERMANY
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 64: Germany 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 67: Germany 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 70: Italy 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 73: Italy 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: UK Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 76: UK 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 78: UK Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 79: UK 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 82: Spain 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 85: Spain 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 88: Russia 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 91: Russia 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 97: Rest of Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
AUSTRALIA
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BioMedomics Inc.
  • Bio-Rad Laboratories, Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • PerkinElmer, Inc.
  • Streck, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

Table Information